Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'TUMOR GRADE' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 102 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Yang, YJ; Steele, CT; Ou, XL; Snyder, KP; Kohman, LJ
      Diagnosis of high-grade pulmonary neuroendocrine carcinoma by fine-needle aspiration biopsy: Nonsmall-cell or small-cell type?

      DIAGNOSTIC CYTOPATHOLOGY
    2. Gyftopoulos, K; Perimenis, P; Ravazoula, P; Barbalias, GA
      Cyclin E and Ki67 (MIB1) as markers of proliferative activity in human prostate cancers: an immunohistochemical study

      UROLOGIC ONCOLOGY
    3. Amadori, A; Bucchi, L; Gori, G; Falcini, F; Saragoni, L; Amadori, D
      Frequency and determinants of lymphadenectomy in endometrial carcinoma: A population-based study from northern Italy

      ANNALS OF SURGICAL ONCOLOGY
    4. Chao, C; Al-Saleem, T; Brooks, JJ; Rogatko, A; Kraybill, WG; Eisenberg, B
      Vascular endothelial growth factor and soft tissue sarcomas: Tumor expression correlates with grade

      ANNALS OF SURGICAL ONCOLOGY
    5. Turetschek, K; Roberts, TPL; Floyd, E; Preda, A; Novikov, V; Shames, DM; Carter, WO; Brasch, RC
      Tumor microvascular characterization using ultrasmall superparamagnetic iron oxide particles (USPIO) in an experimental breast cancer model

      JOURNAL OF MAGNETIC RESONANCE IMAGING
    6. Giles, GG; Severi, G; McCredie, MRE; English, DR; Johnson, W; Hopper, JL; Boyle, P
      Smoking and prostate cancer: Findings from an Australian case-control study

      ANNALS OF ONCOLOGY
    7. Nakanishi, K; Kawai, T; Aida, S; Kasamatsu, H; Aurues, T; Ikeda, T
      Expression of p27(Kip1) protein in transitional cell carcinoma of the upper urinary tract

      MODERN PATHOLOGY
    8. Turetschek, K; Floyd, E; Shames, DM; Roberts, TPL; Preda, A; Novikov, V; Corot, C; Carter, WO; Brasch, RC
      Assessment of a rapid clearance blood pool MR contrast medium (P792) for assays of microvascular characteristics in experimental breast tumors with correlations to histopathology

      MAGNETIC RESONANCE IN MEDICINE
    9. Lundin, J; Lundin, M; Holli, K; Kataja, V; Elomaa, L; Pylkkanen, L; Turpeenniemi-Hujanen, T; Joensuu, H
      Omission of histologic grading from clinical decision making may result inoveruse of adjuvant therapies in breast cancer: Results from a nationwide study

      JOURNAL OF CLINICAL ONCOLOGY
    10. Page, DL; Gray, R; Allred, CC; Dressler, LG; Hatfield, AK; Martino, S; Robert, NJ; Wood, WC
      Prediction of node-negative breast cancer outcome by histologic grading and S-phase analysis by flow cytometry - An Eastern Cooperative Oncology Group study (2192)

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    11. Nagy, A; Kozma, L; Kiss, I; Ember, I; Takacs, I; Hajdu, J; Farid, NR
      Copy number of cancer genes predict tumor grade and survival of pancreaticcancer patients

      ANTICANCER RESEARCH
    12. Amare, PS; Varghese, C; Bharde, SH; Narasimhamoorthy, NK; Desai, S; Advani, SH; Havaldar, R; Kulkarni, JN
      Proliferating cell nuclear antigen and epidermal growth factor receptor (EGFr) status in renal cell carcinoma patients with polysomy of chromosome 7

      CANCER GENETICS AND CYTOGENETICS
    13. Kallakury, BVS; Sheehan, CE; Ross, JS
      Co-downregulation of cell adhesion proteins alpha- and beta-catenins, p 120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas

      HUMAN PATHOLOGY
    14. Stoeckle, E; Coindre, JM; Bonvalot, S; Kantor, G; Terrier, P; Bonichon, F; Bui, BN
      Prognostic factors in retroperitoneal sarcoma - A multivariate analysis ofa series of 165 patients of the French Cancer Center Federation Sarcoma Group

      CANCER
    15. Kiechle, M; Jacobsen, A; Schwarz-Boeger, U; Hedderich, J; Pfisterer, J; Arnold, N
      Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation

      CANCER
    16. Kamai, T; Takagi, K; Asami, H; Ito, Y; Oshima, H; Yoshida, KI
      Decreasing of p27(Kip1) and cyclin E protein levels is associated with progression from superficial into invasive bladder cancer

      BRITISH JOURNAL OF CANCER
    17. Ostrowski, ML; Pindur, J; Laucirica, R; Chakraborty, S; Ramzy, I
      Proliferative activity in invasive breast carcinoma - A comprehensive comparison of MIB-1 immunocytochemical staining in aspiration biopsies to imageanalytic, flow cytometric and histologic parameters

      ACTA CYTOLOGICA
    18. Lijovic, M; Fabiani, ME; Bader, J; Frauman, AG
      Prostate cancer: are new prognostic markers on the horizon?

      PROSTATE CANCER AND PROSTATIC DISEASES
    19. Adolfsson, J; Oksanen, H; Salo, JO; Steineck, G
      Localized prostate cancer and 30 years of follow-up in a population-based setting

      PROSTATE CANCER AND PROSTATIC DISEASES
    20. Hasebe, T; Mukai, K; Tsuda, H; Ochiai, A
      New prognostic histological parameter of invasive ductal carcinoma of the breast: Clinicopathological significance of fibrotic focus

      PATHOLOGY INTERNATIONAL
    21. Helbich, TH; Gossman, A; Mareski, PA; Raduchel, B; Roberts, TPL; Shames, DM; Muhler, M; Turetschek, K; Brasch, RC
      A new polysaccharide macromolecular contrast agent for MR imaging: Biodistribution and imaging characteristics

      JOURNAL OF MAGNETIC RESONANCE IMAGING
    22. Fujioka, T; Hasegawa, M; Suzuki, Y; Suzuki, T; Sugimura, J; Tanji, S; Koike, H
      Telomerase activity in human renal cell carcinoma

      INTERNATIONAL JOURNAL OF UROLOGY
    23. Takashima, M; Ueki, T; Nagai, E; Yao, T; Yamaguchi, K; Tanaka, M; Tsuneyoshi, M
      Carcinoma of the ampulla of vater associated with or without adenoma: A clinicopathologic analysis of 198 eases with reference to p53 and Ki-67 immunohistochemical expressions

      MODERN PATHOLOGY
    24. Sinha, PS; Bendall, S; Bates, T
      Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?

      EUROPEAN JOURNAL OF SURGICAL ONCOLOGY
    25. Warabi, M; Kitagawa, M; Hirokawa, K
      Loss of MHC class II expression is associated with a decrease of tumor-infiltrating T cells and an increase of metastatic potential of colorectal cancer: Immunohistological and histopathological analyses as compared with normal colonic mucosa and adenomas

      PATHOLOGY RESEARCH AND PRACTICE
    26. Krause, W; Hackmann-Schlichter, N; Maier, FK; Muller, R
      Dendrimers in diagnostics

      DENDRIMERS II
    27. Koksal, IT; Ozcan, F; Kadioglu, TC; Esen, T; Kilicaslan, I; Tunc, M
      Discrepancy between Gleason scores of biopsy and radical prostatectomy specimens

      EUROPEAN UROLOGY
    28. Rini, BI; Vogelzang, NJ
      Prognostic factors in renal carcinoma

      SEMINARS IN ONCOLOGY
    29. Naik, R; Nordin, A; Cross, PA; Hemming, D; Lopes, AD; Monaghan, JM
      Complete cytoreduction: Is epithelial ovarian cancer confined to the pelvis biologically different from bulky abdominal disease?

      GYNECOLOGIC ONCOLOGY
    30. McLendon, RE; Wikstrand, CJ; Matthews, MR; Al-Baradei, R; Bigner, SH; Bigner, DD
      Glioma-associated antigen expression in oligodendroglial neoplasms: Tenascin and epidermal growth factor receptor

      JOURNAL OF HISTOCHEMISTRY & CYTOCHEMISTRY
    31. Kronqvist, P; Kuopio, T; Collan, Y
      Morphometric grading of breast cancer: thresholds for tubular differentiation

      BRITISH JOURNAL OF CANCER
    32. Gossmann, A; Helbich, TH; Mesiano, S; Shames, DM; Wendland, MF; Roberts, TPL; Ferrara, N; Jaffe, RB; Brasch, RC
      Magnetic resonance imaging in an experimental model of human ovarian cancer demonstrating altered microvascular permeability after inhibition of vascular endothelial growth factor

      AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY
    33. Lee, DH; Yang, SC; Hong, SJ; Chung, BH; Chung, HJ; Tokunaga, H; Kim, IY; Song, YS; Lerner, SP; Morton, RA
      The loss of expression of transforming growth factor-beta receptors correlates with the histopathologic tumor grade in bladder transitional cell carcinoma patients

      YONSEI MEDICAL JOURNAL
    34. Nakopoulou, L; Michalopoulou, A; Giannopoulou, I; Tzonou, A; Keramopoulos, A; Lazaris, AC; Davaris, PS
      bcl-2 protein expression is associated with a prognostically favourable phenotype in breast cancer irrespective of p53 immunostaining

      HISTOPATHOLOGY
    35. Calvin, DP; Connell, PP; Rotmensch, J; Waggoner, S; Mundt, AJ
      Surgery and postoperative radiation therapy in stage II endometrial carcinoma

      AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
    36. Ross, JS; Sheehan, CE; Ambros, RA; Nazeer, T; Jennings, TA; Kaufman, RP; Fisher, HAG; Rifkin, MD; Kallakury, BVS
      Needle biopsy DNA ploidy status predicts grade shifting in prostate cancer

      AMERICAN JOURNAL OF SURGICAL PATHOLOGY
    37. Cany, L; Stoeckle, E; Coindre, JM; Kantor, G; Bonichon, F; Bui, BN
      Prognostic factors in superficial adult soft tissue sarcomas: Analysis of a series of 105 patients

      JOURNAL OF SURGICAL ONCOLOGY
    38. Imamura, H; Haga, S; Shimizu, T; Watanabe, O; Kajiwara, T; Aiba, M
      Prognostic significance of MIB1-determined proliferative activities in intraductal components and invasive foci associated with invasive ductal breast carcinoma

      BRITISH JOURNAL OF CANCER
    39. KAMIYOSHIHARA M; HIRAI T; KAWASHIMA O; ISHIKAWA S; MORISHITA Y; MAESHIMA A
      LOW-GRADE MALIGNANT-TUMORS OF THE LUNG - IS LYMPH-NODE DISSECTION NECESSARY

      Oncology Reports
    40. KALLAKURY BV; SHEEHAN CE; AMBROS RA; FISHER HA; KAUFMAN RP; MURACA PJ; ROSS JS
      CORRELATION OF P34(CDC2) CYCLIN-DEPENDENT KINASE OVEREXPRESSION, CD44S DOWN-REGULATION, AND HER-2 NEU ONCOGENE AMPLIFICATION WITH RECURRENCE IN PROSTATIC ADENOCARCINOMAS/

      Journal of clinical oncology
    41. Erkurt, E; Tunali, C; Erkisi, M; Boyer, B; Burgurt, R
      Impact of tumor stage, operative down-staging, tumor grade and radioresponsitivity of the tumor on survival in supratentorial astrocytomas

      JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
    42. SILVER DF; HEMPLING RE; PIVER MS; RECIO FO; ELTABBAKH GH
      STAGE-I ADENOCARCINOMA OF THE CERVIX - DOES LESION SIZE AFFECT TREATMENT OPTIONS AND PROGNOSIS

      American journal of clinical oncology
    43. PRATAP R; SHOUSHA S
      BREAST-CARCINOMA IN WOMEN UNDER THE AGE OF 50 - RELATIONSHIP BETWEEN P53 IMMUNOSTAINING, TUMOR GRADE, AND AXILLARY LYMPH-NODE STATUS

      Breast cancer research and treatment
    44. Page, DL; Jensen, RA; Simpson, JF
      Routinely available indicators of prognosis in breast cancer

      BREAST CANCER RESEARCH AND TREATMENT
    45. PRATT CB; MAURER HM; GIESER P; SALZBERG A; RAO BN; PARHAM D; THOMAS PRM; MARCUS RB; CANTOR A; PICK T; GREEN D; NEFF J; JENKINS JJ
      TREATMENT OF UNRESECTABLE OR METASTATIC PEDIATRIC SOFT-TISSUE SARCOMAS WITH SURGERY, IRRADIATION, AND CHEMOTHERAPY - A PEDIATRIC-ONCOLOGY-GROUP STUDY

      Medical and pediatric oncology
    46. RUDOLPH P; PETERS J; LORENZ D; SCHMIDT D; PARWARESCH R
      CORRELATION BETWEEN MITOTIC AND KI-67 LABELING INDEXES IN PARAFFIN-EMBEDDED CARCINOMA SPECIMENS

      Human pathology
    47. REICHERT TE; WATKINS S; STANSON J; JOHNSON JT; WHITESIDE TL
      ENDOGENOUS IL-2 IN CANCER-CELLS - A MARKER OF CELLULAR PROLIFERATION

      The Journal of histochemistry and cytochemistry
    48. HEIMANN R; FERGUSON D; RECANT WM; HELLMAN S
      BREAST-CANCER METASTATIC PHENOTYPE AS PREDICTED BY HISTOLOGIC TUMOR-MARKERS

      The cancer journal from Scientific American
    49. YOUNG RH; ROSENBERG AE; CLEMENT PB
      MUCIN DEPOSITS WITHIN INGUINAL-HERNIA SACS - A PRESENTING FINDING OF LOW-GRADE MUCINOUS CYSTIC TUMORS OF THE APPENDIX - A REPORT OF 2 CASESAND A REVIEW OF THE LITERATURE

      Modern pathology
    50. DUGAN MC; DERGHAM ST; KUCWAY R; SINGH K; BIERNAT L; DU W; VAITKEVICIUS VK; CRISSMAN JD; SARKAR FH
      HER-2 NEU EXPRESSION IN PANCREATIC ADENOCARCINOMA - RELATION TO TUMORDIFFERENTIATION AND SURVIVAL/

      Pancreas
    51. SAKR WA; GRIGNON DJ
      PROSTATE-CANCER - INDICATORS OF AGGRESSIVENESS

      European urology
    52. STEINBERG DM; SAUVAGEOT J; PIANTADOSI S; EPSTEIN JI
      CORRELATION OF PROSTATE NEEDLE-BIOPSY AND RADICAL PROSTATECTOMY GLEASON GRADE IN ACADEMIC AND COMMUNITY SETTINGS

      The American journal of surgical pathology
    53. REES MA; RESNICK MI; OESTERLING JE
      USE OF PROSTATE-SPECIFIC ANTIGEN, GLEASON SCORE, AND DIGITAL RECTAL EXAMINATION IN STAGING PATIENTS WITH NEWLY-DIAGNOSED PROSTATE-CANCER

      Urologic clinics of North America
    54. JONES HL; DELAHUNT B; BETHWAITE PB; THORNTON A
      POLYCLONAL KI-67 EXPRESSION IN TRANSITIONAL-CELL CARCINOMA OF THE BLADDER

      Pathology
    55. ROBERTI NE
      THE ROLE OF HISTOLOGIC GRADING IN THE PROGNOSIS OF PATIENTS WITH CARCINOMA OF THE BREAST - IS THIS A NEGLECTED OPPORTUNITY

      Cancer
    56. KALLAKURY BVS; SHEEHAN CE; AMBROS RA; FISHER HAG; KAUFMAN RP; ROSS JS
      THE PROGNOSTIC-SIGNIFICANCE OF P34(CDC2) AND CYCLIN D1 PROTEIN EXPRESSION IN PROSTATE ADENOCARCINOMA

      Cancer
    57. KATTAN MW; STAPLETON AMF; WHEELER TM; SCARDINO PT
      EVALUATION OF A NOMOGRAM USED TO PREDICT THE PATHOLOGICAL STAGE OF CLINICALLY LOCALIZED PROSTATE CARCINOMA

      Cancer
    58. DELAHUNT B; BETHWAITE PB; THORNTON A
      PROGNOSTIC-SIGNIFICANCE OF MICROSCOPIC VASCULARITY FOR CLEAR-CELL RENAL-CELL CARCINOMA

      British Journal of Urology
    59. FISHER CJ; EGAN MK; SMITH P; WICKS K; MILLIS RR; FENTIMAN IS
      HISTOPATHOLOGY OF BREAST-CANCER IN RELATION TO AGE

      British Journal of Cancer
    60. NORBERG M; HOLMBERG L; BUSCH C; HAGGMAN M; EGEVAD L; MAGNUSSON A
      MULTIPLE TRANSRECTAL ULTRASOUND-GUIDED BIOPSIES FOR THE DETECTION OF PROSTATE-CANCER AND DETERMINATION OF TUMOR VOLUME, GRADE, AND SEMINAL-VESICLE INVASION

      European radiology
    61. EGAWA S; KOH H; SATOH T; OHORI M; UCHIDA T; KUWAO S; KOSHIBA K
      PREOPERATIVE SERUM PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE AND GLEASON SUM AS BASIS FOR PREDICTING FINAL PATHOLOGICAL STAGE JAPANESE PATIENTS WITH PROSTATE-CANCER

      Japanese Journal of Clinical Oncology
    62. PISANSKY TM; ZINCKE H; SUMAN VJ; BOSTWICK DG; EARLE JD; OESTERLING JE
      CORRELATION OF PRETHERAPY PROSTATE-CANCER CHARACTERISTICS WITH HISTOLOGIC-FINDINGS FROM PELVIC LYMPHADENECTOMY SPECIMENS

      International journal of radiation oncology, biology, physics
    63. DAMBER JE; GRONBERG H
      PROSTATE-CANCER MORTALITY IN NORTHERN SWE DEN

      Der Urologe
    64. IDIKIO HA
      EXPRESSION OF PROLIFERATING CELL NUCLEAR ANTIGEN IN NODE-NEGATIVE HUMAN PROSTATE-CANCER

      Anticancer research
    65. LAROYE GJ
      IS THE FREQUENCY OF MITOSES AND PCNA POSITIVE CELLS IN TISSUES AFFECTED BY DELAY IN FIXATION - LESSONS FOR ACCURATE TUMOR GRADING

      Pathology
    66. THICKMAN D; SPEERS WC; PHILPOTT PJ; SHAPIRO H
      EFFECT OF THE NUMBER OF CORE BIOPSIES OF THE PROSTATE - ON PREDICTINGGLEASON SCORE OF PROSTATE-CANCER

      The Journal of urology
    67. MATHEW J; HINES JE; OBAFUNWA JO; BURR AW; TOOLE K; BURT AD
      CD44 IS EXPRESSED IN HEPATOCELLULAR CARCINOMAS SHOWING VASCULAR INVASION

      Journal of pathology
    68. CHEN SS; CHEN KK; LIN ATL; CHANG YH; WU HHH; HSU THS; CHANG LS
      THE SIGNIFICANCE OF TUMOR GRADE IN PREDICTING DISEASE PROGRESSION IN STAGE TA TRANSITIONAL-CELL CARCINOMA OF THE URINARY-BLADDER

      British Journal of Urology
    69. INIESTA P; CALDES T; VEGA FJ; LOPEZ JA; DIAZRUBIO E; CERDAN J; TORRES A; BALIBREA JL; BENITO M
      PREVALENCE OF P53 OVEREXPRESSION OR MUTATIONS, BUT NOT K-RAS MUTATIONS, IN RECURRENT PATIENTS AFFECTED BY COLORECTAL-CARCINOMA

      International journal of oncology
    70. GAGLIARDI G; KANDEMIR O; LIU D; GUIDA M; BENVESTITO S; RUERS TGM; BENJAMIN IS; NORTHOVER JMA; STAMP GWH; TALBOT IC; PIGNATELLI M
      CHANGES IN E-CADHERIN IMMUNOREACTIVITY IN THE ADENOMA-CARCINOMA SEQUENCE OF THE LARGE-BOWEL

      Virchows Archiv
    71. JOHNSTONE PAS; RIFFENBURGH R; SAUNDERS EL; WILLISON FW
      GRADING INACCURACIES IN DIAGNOSTIC BIOPSIES REVEALING PROSTATIC ADENOCARCINOMA - IMPLICATIONS FOR DEFINITIVE RADIATION-THERAPY

      International journal of radiation oncology, biology, physics
    72. CHARPIN C; BACQUIE N; BOUVIER C; DEVICTOR B; BOULAT J; ANDRAC L; LAVAUT MN; ALLASIA C; PIANA L
      COMPARISON OF THE PROGNOSTIC-SIGNIFICANCE OF CURRENT AND MODIFIED HISTOLOGICAL GRADES IN BREAST CARCINOMAS

      Anticancer research
    73. NARAYAN P; GAJENDRAN V; TAYLOR SP; TEWARI A; PRESTI JC; LEIDICH R; LO R; PALMER K; SHINOHARA K; SPAULDING JT
      THE ROLE OF TRANSRECTAL ULTRASOUND-GUIDED BIOPSY-BASED STAGING, PREOPERATIVE SERUM PROSTATE-SPECIFIC ANTIGEN, AND BIOPSY GLEASON SCORE IN PREDICTION OF FINAL PATHOLOGICAL DIAGNOSIS IN PROSTATE-CANCER

      Urology
    74. COHEN RJ; COOPER K; HAFFEJEE Z; ROBINSON E; BECKER PJ
      IMMUNOHISTOCHEMICAL DETECTION OF ONCOGENE PROTEINS AND NEUROENDOCRINEDIFFERENTIATION IN DIFFERENT STAGES OF PROSTATE-CANCER

      Pathology
    75. HAGGMAN M; DELATORRE M; NORBERG M; BUSCH C
      PREOPERATIVE HISTOLOGICAL AND CYTOLOGICAL DIAGNOSIS AND DNA-PLOIDY ASSESSMENT OF LOCALIZED PROSTATIC-CANCER - A COMPARISON BETWEEN FINDINGSIN BIOPSIES AND TOTAL PROSTATECTOMY SPECIMENS

      APMIS. Acta pathologica, microbiologica et immunologica Scandinavica
    76. NONOMURA A; MIZUKAMI Y; SHIMIZU J; HAYASHI Y; MURAKAMI S; WATANABE Y; KAMIMURA R; TAKASHIMA T
      SIMULTANEOUS DETECTION OF INTERCELLULAR-ADHESION MOLECULE-1 (CD54) AND CARCINOEMBRYONIC ANTIGEN IN LUNG ADENOCARCINOMA

      Modern pathology
    77. FARIA V; REIS M; TRIGUEIROS D
      RENAL ADENOMA - IDENTIFICATION OF 2 HISTOLOGIC TYPES

      European urology
    78. VIJAYAKUMAR V; VIJAYAKUMAR S; QUADRI SF; BLEND MJ
      CAN PROSTATE-SPECIFIC ANTIGEN LEVELS PREDICT BONE-SCAN EVIDENCE OF METASTASES IN NEWLY-DIAGNOSED PROSTATE-CANCER

      American journal of clinical oncology
    79. MILLER J; HORSFALL DJ; SKINNER JM; RAO DM; LEONG ASY; MARSHALL VR
      NUCLEAR SHAPE AND PROGNOSIS FOLLOWING ORCHIECTOMY IN STAGE D-2 PROSTATE-CANCER

      The Prostate
    80. PAPADIMITRIOU JC; WEIHING RR; CHOI C; DRACHENBERG CB
      PROSTATIC MARKER-NEGATIVE AMPHICRINE CARCINOMA OF THE PROSTATE

      Ultrastructural pathology
    81. BOSTWICK DG
      GLEASON GRADING OF PROSTATIC NEEDLE BIOPSIES - CORRELATION WITH GRADEIN 316 MATCHED PROSTATECTOMIES

      The American journal of surgical pathology
    82. NARAYAN P; FOURNIER G; GAJENDRAN V; LEIDICH R; LO R; WOLF JS; JACOB G; NICOLAISEN G; PALMER K; FREIHA F
      UTILITY OF PREOPERATIVE SERUM PROSTATE-SPECIFIC ANTIGEN CONCENTRATIONAND BIOPSY GLEASON SCORE IN PREDICTING RISK OF PELVIC LYMPH-NODE METASTASES IN PROSTATE-CANCER

      Urology
    83. SANDS ME; ZAGARS GK; POLLACK A; VONESCHENBACH AC
      SERUM PROSTATE-SPECIFIC ANTIGEN, CLINICAL STAGE, PATHOLOGICAL GRADE, AND THE INCIDENCE OF NODAL METASTASES IN PROSTATE-CANCER

      Urology
    84. BORCHERS H; PLANZ B; JAKSE G; BOCKING A
      DNA ANEUPLOIDY IN G1-UROTHELIAL CARCINOMAS OF THE URINARY-BLADDER

      Urologia internationalis
    85. VANDENBERG E; VANOVEN MW; DEJONG B; DAM A; WIERSEMA J; DIJKHUIZEN T; HOEKSTRA HJ; MOLENAAR WM
      COMPARISON OF CYTOGENETIC ABNORMALITIES AND DEOXYRIBONUCLEIC-ACID PLOIDY OF BENIGN, BORDERLINE MALIGNANT, AND DIFFERENT GRADES OF MALIGNANTSOFT-TISSUE TUMORS

      Laboratory investigation
    86. VEGE DS; CHINOY RF; GANESH B; PARIKH DM
      MALIGNANT PERIPHERAL-NERVE SHEATH TUMORS OF THE HEAD AND NECK - A CLINICOPATHOLOGICAL STUDY

      Journal of surgical oncology
    87. BARETTON GB; VALINA C; VOGT T; SCHNEIDERBANGER K; DIEBOLD J; LOHRS U
      INTERPHASE CYTOGENETIC ANALYSIS OF PROSTATIC CARCINOMAS BY USE OF NONISOTOPIC IN-SITU HYBRIDIZATION

      Cancer research
    88. KRAUS DH; DUBNER S; HARRISON LB; STRONG EW; HAJDU SI; KHER U; BEGG C; BRENNAN MF
      PROGNOSTIC FACTORS FOR RECURRENCE AND SURVIVAL IN HEAD AND NECK SOFT-TISSUE SARCOMAS

      Cancer
    89. ROSS JS; FIGGE H; BUI HX; DELROSARIO AD; JENNINGS TA; RIFKIN MD; FISHER HAG
      PREDICTION OF PATHOLOGICAL STAGE AND POSTPROSTATECTOMY DISEASE RECURRENCE BY DNA-PLOIDY ANALYSIS OF INITIAL NEEDLE-BIOPSY SPECIMENS OF PROSTATE-CANCER

      Cancer
    90. PICARDO AL; TORRES AJ; MAESTRO M; ORTEGA D; GARCIAASENJO JA; MUGUERZA JM; HERNANDO F; DIEZ M; BALIBREA JL
      QUANTITATIVE-ANALYSIS OF CARCINOEMBRYONIC ANTIGEN, SQUAMOUS-CELL CARCINOMA ANTIGEN, CA-125, AND CA-50 CYTOSOLIC CONTENT IN NONSMALL CELL LUNG-CANCER

      Cancer
    91. MANDARD AM; DALIBARD F; MANDARD JC; MARNAY J; HENRYAMAR M; PETIOT JF; ROUSSEL A; JACOB JH; SEGOL P; SAMAMA G; OLLIVIER JM; BONVALOT S; GIGNOUX M
      PATHOLOGICAL ASSESSMENT OF TUMOR-REGRESSION AFTER PREOPERATIVE CHEMORADIOTHERAPY OF ESOPHAGEAL-CARCINOMA

      Cancer
    92. DALTON LW; PAGE DL; DUPONT WD
      HISTOLOGIC GRADING OF BREAST-CARCINOMA - A REPRODUCIBILITY STUDY

      Cancer
    93. BOSTWICK DG
      GRADING PROSTATE-CANCER

      American journal of clinical pathology
    94. NONOMURA A; MIZUKAMI Y; ODA M; SHIMIZU J; WATANABE Y; KAMIMURA R; TAKASHIMA T
      DEMONSTRATION OF NUCLEOLAR ORGANIZER REGIONS IN LUNG-CARCINOMA BY SILVER STAINING

      SURGERY TODAY-THE JAPANESE JOURNAL OF SURGERY
    95. POLLER DN; ELLIS IO
      ONCOGENES AND TUMOR MORPHOLOGY PREDICTION

      Modern pathology
    96. SOLOWAY MS; HACHIYA T; RUIZ HE; GOMEZ CC; CIVANTOS F
      SIGNIFICANCE OF ANDROGEN DEPRIVATION PRIOR TO RADICAL PROSTATECTOMY, WITH SPECIAL REFERENCE TO PROSTATE-SPECIFIC ANTIGEN

      World journal of urology
    97. EVANS RG; KIMLER BF; MORANTZ RA; BATNITZKY S
      LACK OF COMPLICATIONS IN LONG-TERM SURVIVORS AFTER TREATMENT WITH FLUOSOL(R) AND OXYGEN AS AN ADJUVANT TO RADIATION-THERAPY FOR HIGH-GRADE BRAIN-TUMORS

      International journal of radiation oncology, biology, physics
    98. HYAKUTAKE H; SAKAI H; YOGI Y; TSUDA R; MINAMI Y; YUSHITA Y; KANETAKE H; NAKAZONO I; SAITO Y
      BETA-MICROSEMINOPROTEIN IMMUNOREACTIVITY AS A NEW PROGNOSTIC INDICATOR OF PROSTATIC-CARCINOMA

      The Prostate
    99. RASMUSON T; GRANKVIST K; LJUNGBERG B
      SERUM GAMMA-ENOLASE AND PROGNOSIS OF PATIENTS WITH RENAL-CELL CARCINOMA

      Cancer
    100. ROSS JS; NAZEER T; CHURCH K; AMATO C; FIGGE H; RIFKIN MD; FISHER HAG
      CONTRIBUTION OF HER-2 NEU ONCOGENE EXPRESSION TO TUMOR GRADE AND DNA CONTENT-ANALYSIS IN THE PREDICTION OF PROSTATIC-CARCINOMA METASTASIS

      Cancer


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 24/10/20 alle ore 00:30:10